To Evaluate the Safety/Tolerability and Pharmacokinetic Characteristics in Healthy Volunteers

Study Summary

This clinical trial is a randomized, double-blind, placebo-controlled, single ascending dose, phase 1 clinical trial to evaluate the safety/tolerability and pharmacokinetic characteristics, and to explore food effect and ethnic difference of JW2286 after oral administration in healthy adults.